Anthem Blue Cross and Blue Shield Nevada prior authorization, page 52

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0206UNeurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA, cNevada Prior Authorization List, Pg 114 Original policy
0207TEvacuation of meibomian glands, automated, using heat and intermittent pressure, unilateralNevada Prior Authorization List, Pg 114 Original policy
0209UCytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalitiesNevada Prior Authorization List, Pg 114 Original policy
0211UOncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copyNevada Prior Authorization List, Pg 114 Original policy
0212URare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandNevada Prior Authorization List, Pg 114 Original policy
0213TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0213URare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandNevada Prior Authorization List, Pg 114 Original policy
0214TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0214URare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandeNevada Prior Authorization List, Pg 114 Original policy
0215TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0215URare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandeNevada Prior Authorization List, Pg 114 Original policy
0216TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0216UNeurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansionsNevada Prior Authorization List, Pg 114 Original policy
0217TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0217UNeurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and vaNevada Prior Authorization List, Pg 114 Original policy
0218TInjection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joiNevada Prior Authorization List, Pg 114 Original policy
0218UNeurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood orNevada Prior Authorization List, Pg 114 Original policy
0221TPlacement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; lumbarNevada Prior Authorization List, Pg 114 Original policy
0222TPlacement of a posterior intrafacet implant(s), unilateral or bilateral, including imaging and placement of bone graft(s) or synthetic device(s), single level; each additionalNevada Prior Authorization List, Pg 115 Original policy
0228TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; single levelNevada Prior Authorization List, Pg 115 Original policy
0228UOncology (prostate), multianalyte molecular profile by photometric detection of macromolecules adsorbed on nanosponge array slides with machine learning, utilizing first morniNevada Prior Authorization List, Pg 115 Original policy
0229TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, cervical or thoracic; each additional level (List separately in addition to code for primary procedure)Nevada Prior Authorization List, Pg 115 Original policy
0229UBCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysisNevada Prior Authorization List, Pg 115 Original policy
0230TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; single levelNevada Prior Authorization List, Pg 115 Original policy
0230UAR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), full sequence analysis, including small sequence changes in exonicNevada Prior Authorization List, Pg 115 Original policy
0231TInjection(s), anesthetic agent and/or steroid, transforaminal epidural, with ultrasound guidance, lumbar or sacral; each additional level (List separately in addition to codeNevada Prior Authorization List, Pg 115 Original policy
0231UCACNA1A (calcium voltage-gated channel subunit alpha 1A) (eg, spinocerebellar ataxia), full gene analysis, including small sequence changes in exonic and intronic regions, delNevada Prior Authorization List, Pg 115 Original policy
0232TInjection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation when performedNevada Prior Authorization List, Pg 115 Original policy
0232UCSTB (cystatin B) (eg, progressive myoclonic epilepsy type 1A, Unverricht- Lundborg disease), full gene analysis, including small sequence changes in exonic and intronic regionNevada Prior Authorization List, Pg 115 Original policy
0233UFXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expaNevada Prior Authorization List, Pg 115 Original policy
0234UMECP2 (methyl CpG binding protein 2) (eg, Rett syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobileNevada Prior Authorization List, Pg 115 Original policy
0235UPTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome), full gene analysis, including small sequence changes in exonic and intronic regionsNevada Prior Authorization List, Pg 115 Original policy
0236USMN1 (survival of motor neuron 1, telomeric) and SMN2 (survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy) full gene analysis, including small sequence chanNevada Prior Authorization List, Pg 115 Original policy
0237UCardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia), genomic sequence analysis panelNevada Prior Authorization List, Pg 115 Original policy
0238UOncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplNevada Prior Authorization List, Pg 115 Original policy
0239UTargeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insNevada Prior Authorization List, Pg 115 Original policy
0242UTargeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifNevada Prior Authorization List, Pg 115 Original policy
0243UObstetrics (preeclampsia), biochemical assay of placental-growth factor, time- resolved fluorescence immunoassay, maternal serum, predictive algorithm reported as a risk scoreNevada Prior Authorization List, Pg 115 Original policy
0244UOncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearNevada Prior Authorization List, Pg 115 Original policy
0245UOncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes aNevada Prior Authorization List, Pg 116 Original policy
0247UObstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternalNevada Prior Authorization List, Pg 116 Original policy
0248UOncology, spheroid cell culture in 3D microenvironment, 12-drug panel, brain- or brain metastasis-response prediction for each drugNevada Prior Authorization List, Pg 116 Original policy
0249UOncology (breast), semiquantitative analysis of 32 phosphoproteins andNevada Prior Authorization List, Pg 116 Original policy
0250UOncology (solid organ neoplasm), targeted genomic sequence DNA analysiNevada Prior Authorization List, Pg 116 Original policy
0253TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; internal approach, into the suprachoroidal spaceNevada Prior Authorization List, Pg 116 Original policy
0254UReproductive medicine (preimplantation genetic assessment), analysis oNevada Prior Authorization List, Pg 116 Original policy
0255UAndrology (infertility), sperm-capacitation assessment of ganglioside GM1 distribution patterns, fluorescence microscopy, fresh or frozen specimen, reported as percentage of cNevada Prior Authorization List, Pg 116 Original policy
0258UAutoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likeliNevada Prior Authorization List, Pg 116 Original policy
0260URare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by opticalNevada Prior Authorization List, Pg 116 Original policy
0262UOncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin- embedded (FFPE), algoriNevada Prior Authorization List, Pg 116 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.